Cytokinetics's market cap is currently $6.55B. The company's EPS TTM is $-1.12; its P/E ratio is -11.23; Cytokinetics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.57. See an overview of income statement, balance sheet, and cash flow financials.
